Misdiagnosed with Type 2 Diabetes, Woman Finds Out She Has LADA After ER Visit
In late 2022, Naomi Pineiro, a 33-year-old from Guayabo, Puerto Rico, went for routine blood work, expecting normal results. Active in CrossFit five days a week and with no family history of diabetes, she was surprised when her fasting glucose reading came back at 120 mg/dL, indicating prediabetes. Pineiro initially dismissed the result, attributing it to possible dietary indiscretions. However, she also experienced fatigue, migraines, and blurry vision, which she attributed to stress from her new corporate banking job.
A few months later, after consulting a workplace nutritionist, she was advised to see a doctor regarding her persistent elevated blood sugar. Following an oral glucose tolerance test, she received a diagnosis of Type 2 diabetes when her glucose soared to 345 mg/dL. Pineiro, unfamiliar with diabetes, thought she could manage it through diet and exercise, and began taking the medication Ozempic, losing about 30 pounds in the process.
Despite her efforts, Pineiro noticed troubling spikes in her blood sugar levels, often reaching 290-300 mg/dL after meals. This led her to increase her exercise, drink more water, and limit carbohydrates, but she felt increasingly frustrated and confused. Her symptoms worsened, culminating in a hospitalization for cellulitis, during which her blood sugar reached dangerously high levels of around 500 mg/dL. The doctors diagnosed her with diabetic ketoacidosis (DKA), a serious condition resulting from insufficient insulin.
After being discharged without proper follow-up care, Pineiro sought another opinion. She faced long wait times for endocrinologist appointments in Puerto Rico and felt overwhelmed by her health challenges. Encouraged by her in-laws, she reached out to the Mayo Clinic, where she quickly secured an appointment. There, she underwent tests that revealed low insulin production and positive results for diabetes autoantibodies, leading to a diagnosis of latent autoimmune diabetes in adults (LADA), also known as Type 1.5 diabetes.
This diagnosis clarified why her previous treatment for Type 2 diabetes had been ineffective. Unlike Type 2 diabetes, LADA requires insulin treatment as the pancreas cannot produce sufficient insulin. Pineiro learned to manage her condition through diabetes education at Mayo Clinic, which included carbohydrate counting and insulin dosage calculations.
Motivated by her diagnosis, Pineiro decided to challenge herself physically. After struggling with her first mile run, she set her sights on completing a half marathon, supported by her medical team. Six months later, she successfully finished her first half marathon in under two hours, an accomplishment that transformed her perspective on living with diabetes. Pineiro is now preparing for the Berlin Marathon, demonstrating resilience and determination in managing her health and pursuing her athletic goals.




